AMRS
Price:
$0.05
Market Cap:
$18.47M
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. It offers its products under the Biossance, Pipette, Purecane, Terasana, Costa Brazil, OLIKA, Rose Inc., and JVN brand names. The company has a collaboration agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company was formerly known...[Read more]
Industry
Chemicals - Specialty
IPO Date
2010-09-28
Stock Exchange
NASDAQ
Ticker
AMRS
According to Amyris, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.04. This represents a change of -96.29% compared to the average of -1.08 of the last 4 quarters.
The mean historical PE Ratio of Amyris, Inc. over the last ten years is 5.14. The current -0.04 PE Ratio has changed -177.88% with respect to the historical average. Over the past ten years (40 quarters), AMRS's PE Ratio was at its highest in in the June 2021 quarter at 85.17. The PE Ratio was at its lowest in in the September 2021 quarter at -31.35.
Average
5.14
Median
-1.43
Minimum
-5.99
Maximum
70.65
Discovering the peaks and valleys of Amyris, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 200.85%
Maximum Annual PE Ratio = 70.65
Minimum Annual Increase = -4260.40%
Minimum Annual PE Ratio = -5.99
Year | PE Ratio | Change |
---|---|---|
2022 | -0.97 | -83.84% |
2021 | -5.99 | 54.39% |
2020 | -3.88 | 200.85% |
2019 | -1.29 | 35.27% |
2018 | -0.95 | -38.97% |
2017 | -1.56 | -21.58% |
2016 | -1.99 | 111.20% |
2015 | -0.94 | -101.34% |
2014 | 70.65 | -4260.40% |
2013 | -1.70 | 96.86% |
The current PE Ratio of Amyris, Inc. (AMRS) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-3.61
5-year avg
-2.62
10-year avg
5.14
Amyris, Inc.’s PE Ratio is greater than Aemetis, Inc. (-2.04), greater than Codexis, Inc. (-2.53), greater than Gevo, Inc. (-2.35), greater than GrowGeneration Corp. (-2.28), greater than Pacific Biosciences of California, Inc. (-1.07),
Company | PE Ratio | Market cap |
---|---|---|
-2.04 | $104.30M | |
-2.53 | $194.34M | |
-2.35 | $174.00M | |
-2.28 | $110.06M | |
-1.07 | $430.60M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amyris, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Amyris, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Amyris, Inc.'s PE Ratio?
How is the PE Ratio calculated for Amyris, Inc. (AMRS)?
What is the highest PE Ratio for Amyris, Inc. (AMRS)?
What is the 3-year average PE Ratio for Amyris, Inc. (AMRS)?
What is the 5-year average PE Ratio for Amyris, Inc. (AMRS)?
How does the current PE Ratio for Amyris, Inc. (AMRS) compare to its historical average?